IP Verse

Aragon Pharmaceuticals patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Aragon Pharmaceuticals opposed by its competitors

Explore Aragon Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3226843
May 26, 2021Anticancer Compositions1
EP3533792
May 5, 2021Crystalline Forms Of An Androgen Receptor Modulator1
EP3226842
Nov 25, 2020Anticancer Compositions2
EP3305285
Sep 2, 2020Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer3
EP3348553
Jul 8, 2020Crystalline Forms Of An Androgen Receptor Modulator2
EP2945628
Apr 15, 2020Androgen Receptor Modulator And Uses Thereof4
EP2858985
Apr 18, 2018Crystalline Forms Of An Androgen Receptor Modulator3

Top competitors of Aragon Pharmaceuticals

List of top competitors of Aragon Pharmaceuticals based on patent oppositions.